Chronic Spine Pain: Whether from disc degeneration, facet joint disease, or muscular dysfunction, peptides can address the underlying tissue pathology contributing to persistent back and neck pain
For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y
Oral dosing for GI targets
Vigorous shaking or agitation can shear and denature the peptide chains, rendering them inactive